Long-term benefits of pancreas transplantation

Patrick G. Dean, Yogish C Kudva, Mark D Stegall

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Pancreas transplantation has emerged as an effective treatment for patients with diabetes mellitus, especially those with established end-stage renal disease. Surgical and immunosuppressive advances have significantly improved allograft survival. With more recipients enjoying normoglycemia for longer periods of time, the opportunity to study more closely the effects of pancreas transplantation has arisen. This review will focus on these long-term benefits. RECENT FINDINGS: The field of pancreas transplantation has been limited by a lack of randomized, controlled trials and relatively poor graft survival rates historically, however we can still glean many important points from the existing literature. The procedure reduces mortality compared with diabetic kidney transplant recipients and waitlisted patients. Improvements in diabetic nephropathy and retinopathy have also been demonstrated. Pancreas transplantation can improve cardiovascular risk profiles, improve cardiac function and decrease cardiovascular events. Lastly, improvements in diabetic neuropathy and quality of life can result from pancreas transplantation. SUMMARY: Pancreas transplantation remains the most effective method to establish durable normoglycemia for patients with diabetes mellitus. Well designed clinical studies to assess outcomes and adverse events will be of paramount importance in providing optimal care to patients with diabetes mellitus.

Original languageEnglish (US)
Pages (from-to)85-90
Number of pages6
JournalCurrent Opinion in Organ Transplantation
Volume13
Issue number1
DOIs
StatePublished - Feb 2008

Fingerprint

Pancreas Transplantation
Diabetes Mellitus
Diabetic Neuropathies
Diabetic Nephropathies
Diabetic Retinopathy
Graft Survival
Immunosuppressive Agents
Chronic Kidney Failure
Allografts
Patient Care
Survival Rate
Randomized Controlled Trials
Quality of Life
Kidney
Mortality

Keywords

  • Benefits
  • Pancreas transplant
  • Patient survival
  • Type 1 diabetes mellitus

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Long-term benefits of pancreas transplantation. / Dean, Patrick G.; Kudva, Yogish C; Stegall, Mark D.

In: Current Opinion in Organ Transplantation, Vol. 13, No. 1, 02.2008, p. 85-90.

Research output: Contribution to journalArticle

@article{11108a67479c466bbfbc9cb77b34b0b4,
title = "Long-term benefits of pancreas transplantation",
abstract = "PURPOSE OF REVIEW: Pancreas transplantation has emerged as an effective treatment for patients with diabetes mellitus, especially those with established end-stage renal disease. Surgical and immunosuppressive advances have significantly improved allograft survival. With more recipients enjoying normoglycemia for longer periods of time, the opportunity to study more closely the effects of pancreas transplantation has arisen. This review will focus on these long-term benefits. RECENT FINDINGS: The field of pancreas transplantation has been limited by a lack of randomized, controlled trials and relatively poor graft survival rates historically, however we can still glean many important points from the existing literature. The procedure reduces mortality compared with diabetic kidney transplant recipients and waitlisted patients. Improvements in diabetic nephropathy and retinopathy have also been demonstrated. Pancreas transplantation can improve cardiovascular risk profiles, improve cardiac function and decrease cardiovascular events. Lastly, improvements in diabetic neuropathy and quality of life can result from pancreas transplantation. SUMMARY: Pancreas transplantation remains the most effective method to establish durable normoglycemia for patients with diabetes mellitus. Well designed clinical studies to assess outcomes and adverse events will be of paramount importance in providing optimal care to patients with diabetes mellitus.",
keywords = "Benefits, Pancreas transplant, Patient survival, Type 1 diabetes mellitus",
author = "Dean, {Patrick G.} and Kudva, {Yogish C} and Stegall, {Mark D}",
year = "2008",
month = "2",
doi = "10.1097/MOT.0b013e3282f2fd7f",
language = "English (US)",
volume = "13",
pages = "85--90",
journal = "Current Opinion in Organ Transplantation",
issn = "1087-2418",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Long-term benefits of pancreas transplantation

AU - Dean, Patrick G.

AU - Kudva, Yogish C

AU - Stegall, Mark D

PY - 2008/2

Y1 - 2008/2

N2 - PURPOSE OF REVIEW: Pancreas transplantation has emerged as an effective treatment for patients with diabetes mellitus, especially those with established end-stage renal disease. Surgical and immunosuppressive advances have significantly improved allograft survival. With more recipients enjoying normoglycemia for longer periods of time, the opportunity to study more closely the effects of pancreas transplantation has arisen. This review will focus on these long-term benefits. RECENT FINDINGS: The field of pancreas transplantation has been limited by a lack of randomized, controlled trials and relatively poor graft survival rates historically, however we can still glean many important points from the existing literature. The procedure reduces mortality compared with diabetic kidney transplant recipients and waitlisted patients. Improvements in diabetic nephropathy and retinopathy have also been demonstrated. Pancreas transplantation can improve cardiovascular risk profiles, improve cardiac function and decrease cardiovascular events. Lastly, improvements in diabetic neuropathy and quality of life can result from pancreas transplantation. SUMMARY: Pancreas transplantation remains the most effective method to establish durable normoglycemia for patients with diabetes mellitus. Well designed clinical studies to assess outcomes and adverse events will be of paramount importance in providing optimal care to patients with diabetes mellitus.

AB - PURPOSE OF REVIEW: Pancreas transplantation has emerged as an effective treatment for patients with diabetes mellitus, especially those with established end-stage renal disease. Surgical and immunosuppressive advances have significantly improved allograft survival. With more recipients enjoying normoglycemia for longer periods of time, the opportunity to study more closely the effects of pancreas transplantation has arisen. This review will focus on these long-term benefits. RECENT FINDINGS: The field of pancreas transplantation has been limited by a lack of randomized, controlled trials and relatively poor graft survival rates historically, however we can still glean many important points from the existing literature. The procedure reduces mortality compared with diabetic kidney transplant recipients and waitlisted patients. Improvements in diabetic nephropathy and retinopathy have also been demonstrated. Pancreas transplantation can improve cardiovascular risk profiles, improve cardiac function and decrease cardiovascular events. Lastly, improvements in diabetic neuropathy and quality of life can result from pancreas transplantation. SUMMARY: Pancreas transplantation remains the most effective method to establish durable normoglycemia for patients with diabetes mellitus. Well designed clinical studies to assess outcomes and adverse events will be of paramount importance in providing optimal care to patients with diabetes mellitus.

KW - Benefits

KW - Pancreas transplant

KW - Patient survival

KW - Type 1 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=38149038794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38149038794&partnerID=8YFLogxK

U2 - 10.1097/MOT.0b013e3282f2fd7f

DO - 10.1097/MOT.0b013e3282f2fd7f

M3 - Article

VL - 13

SP - 85

EP - 90

JO - Current Opinion in Organ Transplantation

JF - Current Opinion in Organ Transplantation

SN - 1087-2418

IS - 1

ER -